Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2)

Ssu Chuan Lai, Yu Ting Su, Ching Chi Chi, Yung Che Kuo, Kam Fai Lee, Yu Chih Wu, Pei Chi Lan, Muh Hwa Yang, Te Sheng Chang*, Yen Hua Huang

*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Fingerprint

Dive into the research topics of 'Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of Experimental and Clinical Cancer Research (2019) 38 (474) DOI: 10.1186/s13046-019-1442-2)'. Together they form a unique fingerprint.

Medicine & Life Sciences